Dynavax Technologies (DVAX) 10-Q2024 Q3 Quarterly report

Filed: 7 Nov 24, 4:18pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. senior Avg

New words: acquisition, adjudicating, America, anniversary, antigen, automated, Canada, capture, Chapter, chemistry, chosen, comment, competitor, comprising, conceived, Connecticut, decided, deciding, Delaware, delete, deter, differentiated, disaggregated, discourage, Draft, East, Florida, frustrate, hand, harvesting, holiday, inaccurate, incremental, Interagency, interfere, introduction, IPR, Janssen, jurisdiction, lag, Lastly, liable, literature, merger, mitigate, opposition, opting, petition, PGR, post, premium, professional, prove, published, reissue, remove, rendering, respiratory, revocation, Robert, Simultaneously, SIP, sooner, staggered, stockholder, stop, stricter, strong, supermajority, syncytial, unapproved, uniformly, unitary, UPC, USPTO, Vice, vote, voting, winter, write

Removed: determining, emergency, inherent, leased, low, measuring, methodology, MINE, relation, restrictive, Russia, scale, stem, UNREGISTERED, weakening, worsening

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated DVAX transcripts

DVAX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification Pursuant to Section 1350 of Chapter 63

of Title 18 of the United States Code

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), I, Ryan Spencer, Chief Executive Officer of Dynavax Technologies Corporation (the “Company”), hereby certify that, to the best of my knowledge:

(i)The Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the “Periodic Report”), to which this Certificate is attached as Exhibit 32.1, fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and

(ii)The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

In Witness Whereof, the undersigned has set his hand hereto as of the 7th day of November 2024.


			By:						/S/ RYAN SPENCER
									Ryan Spencer Chief Executive Officer and Director (Principal Executive Officer)

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Dynavax Technologies Corporation under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.